These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30113933)

  • 1. SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS: A Randomized, Phase 2 Study (DOGWOOD).
    Yeh S; Kurup SK; Wang RC; Foster CS; Noronha G; Nguyen QD; Do DV;
    Retina; 2019 Oct; 39(10):1880-1888. PubMed ID: 30113933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial.
    Yeh S; Khurana RN; Shah M; Henry CR; Wang RC; Kissner JM; Ciulla TA; Noronha G;
    Ophthalmology; 2020 Jul; 127(7):948-955. PubMed ID: 32173113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.
    Willoughby AS; Vuong VS; Cunefare D; Farsiu S; Noronha G; Danis RP; Yiu G
    Am J Ophthalmol; 2018 Feb; 186():144-151. PubMed ID: 29199012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study.
    Barakat MR; Wykoff CC; Gonzalez V; Hu A; Marcus D; Zavaleta E; Ciulla TA
    Ophthalmol Retina; 2021 Jan; 5(1):60-70. PubMed ID: 32829027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial.
    Shah M; Albini T; Nguyen Q; Wykoff C; Barakat M; Khurana RN; Kapik B; Ciulla TA
    Ocul Immunol Inflamm; 2024 Oct; 32(8):1556-1563. PubMed ID: 38194432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial.
    Merrill PT; Henry CR; Nguyen QD; Reddy A; Kapik B; Ciulla TA
    Ocul Immunol Inflamm; 2023 Oct; 31(8):1579-1586. PubMed ID: 34406900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE.
    Singer MA; Merrill P; Yeh S; Hall C; Kapik B; Ciulla TA
    Clin Exp Ophthalmol; 2022 Jan; 50(1):23-30. PubMed ID: 34741564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA).
    Khurana RN; Merrill P; Yeh S; Suhler E; Barakat MR; Uchiyama E; Henry CR; Shah M; Wang RC; Kapik B; Ciulla T
    Br J Ophthalmol; 2022 Aug; 106(8):1139-1144. PubMed ID: 33712478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema.
    Lampen SIR; Khurana RN; Noronha G; Brown DM; Wykoff CC
    Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):692-697. PubMed ID: 30222804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA).
    Henry CR; Shah M; Barakat MR; Dayani P; Wang RC; Khurana RN; Rifkin L; Yeh S; Hall C; Ciulla T
    Br J Ophthalmol; 2022 Jun; 106(6):802-806. PubMed ID: 33547034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology.
    Smith JR; Thorne JE; Flaxel CJ; Jain N; Kim SJ; Maguire MG; Patel S; Weng CY; Yeh S; Kim LA
    Ophthalmology; 2024 Sep; 131(9):1107-1120. PubMed ID: 38647511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal Triamcinolone Injection for Uveitic Macular Edema: A Randomized Clinical Study.
    Shin JY; Yu HG
    Ocul Immunol Inflamm; 2015; 23(6):430-6. PubMed ID: 26308286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema.
    Ciulla TA; Kapik B; Barakat MR; Khurana RN; Nguyen QD; Grewal DS; Albini T; Cunningham ET; Goldstein DA
    Am J Ophthalmol; 2022 May; 237():310-324. PubMed ID: 34740628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
    Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA;
    Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.
    Lasave AF; Schlaen A; Zeballos DG; Díaz-Llopis M; Couto C; El-Haig WM; Arevalo JF
    Ocul Immunol Inflamm; 2019; 27(2):294-302. PubMed ID: 29157128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study.
    Ali BM; Azmeh AM; Alhalabi NM
    BMC Ophthalmol; 2023 Feb; 23(1):60. PubMed ID: 36765332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy and safety of subconjunctival triamcinolone acetonide injections in treatment of uveitic macular edema].
    Liu X; Wang M; Zhao C; Gao F; Zhang M
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):734-8. PubMed ID: 26693767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE FOR REFRACTORY POSTOPERATIVE CYSTOID MACULAR EDEMA.
    Momenaei B; Pandit SA; Wang KY; Wakabayashi T; Hsu J; Regillo CD; Klufas MA; Xu D; Cohen MN; Garg SJ; Kuriyan AE; Yonekawa Y
    Retina; 2024 Aug; 44(8):1379-1386. PubMed ID: 39047129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.